Folate-decorated nanogels for targeted therapy of ovarian cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21536326.
- Also identified by DOI 10.1016/j.biomaterials.2011.04.006 and PMC identifier 3255291.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanogels are comprised of swollen polymer networks and nearly 95% water and can entrap diverse chemical and biological agents for cancer therapy with very high loading capacities. Here we use diblock copolymer poly(ethylene oxide)-b-poly(methacrylic acid) (PEO-b-PMA) to form nanogels with the desired degree of cross-linking. The nanogels are further conjugated to folic acid (FA) and loaded with different types of drugs (cisplatin, doxorubicin). For the first time we demonstrate a tumor-specific delivery and superior anti-tumor effect in vivo of an anti-cancer drug using these polyelectrolyte nanogels decorated with folate-targeting groups. This reinforces the use of nanogels for the therapy of ovarian and other cancers, where folate receptor (FR) is overexpressed.
Medical subject headings
- Antineoplastic Agents
- Drug Delivery Systems
- Folic Acid
- Hydrogels
- Nanoparticles
- Ovarian Neoplasms